Suraksha Diagnostic Ltd (SURK)

Currency in INR
304.45
0.00(0.00%)
Real-time Data·
Unusual trading volume
SURK is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
296.60308.00
52 wk Range
224.10333.00
Key Statistics
Bid/Ask
304.40 / 304.45
Prev. Close
304.45
Open
303
Day's Range
296.6-308
52 wk Range
224.1-333
Volume
266.54K
Average Volume (3m)
124.26K
1-Year Change
0.7112%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SURK Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
285.00
Downside
-6.39%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Suraksha Diagnostic Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 285.00
(-6.39% Downside)

Earnings

Latest Release
Aug 13, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.88%
Dividend Yield
-
Industry Median 0.31%
Annualised payout
-
5-Years Growth
-
Growth Streak

SURK Income Statement

Compare SURK to Peers and Sector

Metrics to compare
SURK
Peers
Sector
Relationship
P/E Ratio
43.6x55.8x−0.4x
PEG Ratio
4.670.710.00
Price/Book
6.4x6.1x2.6x
Price / LTM Sales
4.8x5.8x3.1x
Upside (Analyst Target)
−6.5%13.5%48.4%
Fair Value Upside
Unlock−0.5%6.5%Unlock

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company also provides Cardiology testing services comprises electrocardiogram, echocardiogram, stress test / treadmill test, wireless holter monitoring, colour doppler, peripheral doppler, and pulmonary function test; gastroenterology, such as upper and lower GI endoscopy, sigmoidoscopy, proctoscopy, colonoscopy, and proctosigmoidoscopy; and neurology testing services, including electroencephalogram, electromyography, and nerve conduction velocity test. In addition, the company provides dental, physiotherapy, immunology & rheumatology, eye, fetal care, ENT, and speciality clinics, as well as home doctor visit services. The company was founded in 1992 and is based in Kolkata, India.

Employees
1300
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
10,91M20,95%2,95B
Other Institutional Investors
18,25M35,05%4,93B
Public Companies & Retail Investors
22,92M44,01%6,20B
Total
52,08M100,00%14,08B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Orbimed Asia II Mauritius Limited12,88%6 706 7111 813 159
Estate of Kishan Kumar Kejriwal9,23%4 809 0621 300 130

FAQ

What Is the Suraksha Diagnostic (SURK) Stock Price Today?

The Suraksha Diagnostic stock price today is 304,45 INR.

What Stock Exchange Does Suraksha Diagnostic Trade On?

Suraksha Diagnostic is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Suraksha Diagnostic?

The stock symbol for Suraksha Diagnostic is "SURK."

What Is the Suraksha Diagnostic Market Cap?

As of today, Suraksha Diagnostic market cap is 15,86B INR.

What Is Suraksha Diagnostic's Earnings Per Share (TTM)?

The Suraksha Diagnostic EPS (TTM) is 6,88.

When Is the Next Suraksha Diagnostic Earnings Date?

Suraksha Diagnostic will release its next earnings report on Nov 09, 2026.

From a Technical Analysis Perspective, Is SURK a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Suraksha Diagnostic Stock Split?

Suraksha Diagnostic has split 0 times.

How Many Employees Does Suraksha Diagnostic Have?

Suraksha Diagnostic has 1300 employees.

What is the current trading status of Suraksha Diagnostic (SURK)?

As of Aug 14, 2026, Suraksha Diagnostic (SURK) is trading at a price of 304,45 INR, with a previous close of 304,45 INR. The stock has fluctuated within a day range of 296,60 INR to 308,00 INR, while its 52-week range spans from 224,10 INR to 333,00 INR.

What Is Suraksha Diagnostic (SURK) Price Target According to Analysts?

The average 12-month price target for Suraksha Diagnostic is 285,00 INR, with a high estimate of 285 INR and a low estimate of 285 INR. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an -6,39% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.